LLY vs UNH
LLY: Eli Lilly is a global pharmaceutical innovator leading the market in metabolic health, including diabetes and obesity treatments, alongside a diverse portfolio of oncology and immunology therapies. UNH: UnitedHealth Group is a leading health care platform combining insurance coverage and clinical services to manage health costs and improve outcomes for millions of members.
Side-by-side fundamentals
| Metric | LLY | UNH | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $1,255.40 | $390.11 | |
| Market cap as of 2026-08-24 | $1.18T | $350.2B | |
| P/E as of 2026-08-24 | 43.17 | 25.63 | UNH lower |
| PEG as of 2026-08-24 | 1.48 | 2.39 | LLY lower |
| Net margin as of 2026-08-24 | +33.5% | +3.1% | LLY higher |
| Gross margin as of 2026-08-24 | +83.4% | n/a | |
| Operating margin as of 2026-08-24 | +42.2% | +4.7% | LLY higher |
| ROE as of 2026-08-24 | +92.6% | +14.4% | LLY higher |
| ROA as of 2026-08-24 | +22.0% | +4.5% | LLY higher |
| Debt / equity as of 2026-08-24 | 1.62 | 0.70 | UNH lower |
| Revenue growth (YoY) as of 2026-08-24 | +49.6% | +6.5% | LLY higher |
| Revenue CAGR (3y) SEC XBRL | +31.7% | +11.4% | LLY higher |
| Dividend yield as of 2026-08-24 | +0.8% | +1.4% | UNH higher |
| Dividend streak (yrs) SEC XBRL | 5 | 1 | LLY higher |
| Beta as of 2026-08-24 | 0.46 | 0.61 | |
| 1-year return as of 2026-08-21 close | +76.9% | +28.6% | LLY higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.